Cite
MLA Citation
Jacques Donnez et al.. “Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.” Lancet, vol. 400, no. 10356, 2022, pp. 896–907. http://access.bl.uk/ark:/81055/vdc_100164726356.0x000057